-
May 19: The Week in Cancer NewsCancer drugs are affected by shortages, and angiogenesis inhibitors make a comeback in combination treatments.
by Kevin McLaughlin
-
AACR Annual Meeting 2023Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.
-
More Prostate Cancer Patients Choose SurveillanceMen are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose
-
May 12: The Week in Cancer NewsMammography screening recommendation pushed back to age 40, and pancreatic cancer vaccine shows promising immune response.
by Marci A. Landsmann
-
Childhood Cancer Survivors Face Higher Mortality for DecadesAn increased risk of early death exists even after treatment for childhood cancer, but survivors also have the potential for decades of life after cancer.
by Sandra Gordon
-
Building BridgesAACR Scientist↔Survivor Program celebrates 25 years of sparking conversations between cancer patients and researchers.
by Thomas Celona
-
May 5: The Week in Cancer NewsResearchers discover a new way breast density can impact cancer risk, and CAR T-cell therapy remains out of reach for patients with HIV.
by Thomas Celona
-
The State of Cancer Care and PregnancyAn expert panel at the AACR Annual Meeting discussed the difficult choices faced when cancer is diagnosed during a pregnancy and how recent laws have brought additional challenges.
by Eric Fitzsimmons
-
April 28: The Week in Cancer NewsMore programs address sexual health in cancer survivors, and survey suggests health insurance often doesn’t cover genetic tumor testing.
by Marci A. Landsmann
-
Decoding Disparities in Colorectal CancerPeople of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment options.
by Marci A. Landsmann
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
